These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 24404994)
1. Treatment of cytomegalovirus infections beyond acute disease to improve human health. Söderberg-Nauclér C Expert Rev Anti Infect Ther; 2014 Feb; 12(2):211-22. PubMed ID: 24404994 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection in immunocompetent and immunocompromised individuals--a review. Vancíková Z; Dvorák P Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):179-87. PubMed ID: 12476798 [TBL] [Abstract][Full Text] [Related]
3. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients]. Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666 [TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Steininger C Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. Humar A; Kumar D; Boivin G; Caliendo AM J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Roblin X; Pillet S; Oussalah A; Berthelot P; Del Tedesco E; Phelip JM; Chambonnière ML; Garraud O; Peyrin-Biroulet L; Pozzetto B Am J Gastroenterol; 2011 Nov; 106(11):2001-8. PubMed ID: 21788989 [TBL] [Abstract][Full Text] [Related]
7. Current and new cytomegalovirus antivirals and novel animal model strategies. McGregor A Inflamm Allergy Drug Targets; 2010 Sep; 9(4):286-99. PubMed ID: 20860547 [TBL] [Abstract][Full Text] [Related]
8. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176 [TBL] [Abstract][Full Text] [Related]
13. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Neyts J; De Clercq E Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749 [TBL] [Abstract][Full Text] [Related]
14. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature. Hodowanec AC; Simon DM Transpl Infect Dis; 2012 Oct; 14(5):E116-20. PubMed ID: 22938143 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation. Kim JH; Goulston C; Sanders S; Lampas M; Zangari M; Tricot G; Hanson KE Biol Blood Marrow Transplant; 2012 Nov; 18(11):1753-8. PubMed ID: 22728249 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. Humar A; Kumar D; Gilbert C; Boivin G J Infect Dis; 2003 Aug; 188(4):581-4. PubMed ID: 12898447 [TBL] [Abstract][Full Text] [Related]
17. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. Emery VC; Sabin C; Feinberg JE; Grywacz M; Knight S; Griffiths PD J Infect Dis; 1999 Sep; 180(3):695-701. PubMed ID: 10438356 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience. Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934 [TBL] [Abstract][Full Text] [Related]
19. Lessons learned from HIV pathogenesis and therapy: implications for better management of cytomegalovirus disease. Hardy WD AIDS; 1996 Nov; 10 Suppl 1():S31-5. PubMed ID: 8970674 [TBL] [Abstract][Full Text] [Related]